Your browser doesn't support javascript.
loading
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study.
Su, Ruopeng; Chen, Zeyu; Hong, Daoping; Jiang, Shuai; Yuan, Yichu; Cai, Xingyun; Hu, Hailong; Fu, Changde; Huang, Zhiyang; Wang, Zhenyu; Zheng, Bing; Huang, Jian; Wang, Zaoyu; Bao, Yige; Cai, Ming; Guo, Jianming; Chen, Minfeng; Wei, Qiang; Huang, Jiwei; Xue, Wei.
Afiliação
  • Su R; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chen Z; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
  • Hong D; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
  • Jiang S; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yuan Y; Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Cai X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Hu H; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Fu C; Department of Urology, Quanzhou First Hospital affiliated to Fujian Medical University, Quanzhou, China.
  • Huang Z; Department of Urology, Quanzhou First Hospital affiliated to Fujian Medical University, Quanzhou, China.
  • Wang Z; The Department of Urology, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Zheng B; The Department of Urology, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Huang J; The Department of Urology, AnHui NO.2 Provincial People Hospital, Hefei, China.
  • Wang Z; Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Bao Y; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
  • Cai M; Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen M; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
  • Wei Q; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
  • Huang J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Xue W; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Cancer Med ; 12(9): 10587-10596, 2023 05.
Article em En | MEDLINE | ID: mdl-36952461
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China